The 2026 Pharmacy Benefit Management Institute Annual National Conference was held Sept. 10-11 in Orlando, Florida. Here is a ...

Sagimet CEO David Happel says oral denifanstat could sharply cut antibiotic use in acne and be used before patients ever need ...

Sagimet Biosciences’ denifanstat oral acne pill shows rapid, sustained lesion cuts and higher clear-skin rates in phase 3, ...

Sagimet Biosciences has begun screening patients for a U.S. phase 3 trial of denifanstat, an investigational once-daily oral ...

In this conversation, Alison Pritchard, Ph.D., explains how ADHD and sleep problems can form a cycle in children and shares findings from ‘What Matters to Caregivers of Youth Wi ...

In this month’s episode of Tuning In to the C-Suite, Managing Editor Peter Wehrwein talks with Rick Bates, MBA, president and CEO of RxSense. In his conversation with Wehrwein, Bates described RxSense ...

New guidelines for acute low back pain favors self-care, NSAIDs, physical therapy and acupuncture over routine imaging and first-line opioids. Imaging and opioids should not be first-line treatment ...

The lawsuit targets the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a mandatory model CMS finalized last week ...

Pills that rival biologics, weight-loss drugs paired with psoriasis treatment and a phase 3 win for a personalized mRNA ...

Direct-to-consumer drug programs hold the promise of cheaper GLP-1s and other drugs, but buying drugs outside insurance benefits may be more costly— and risky — in the long run. More Americans are ...

The CEO and founder of a digital behavior company has advice for health plans considering asynchronous behavioral health services like those that his company provides. Health plans have spent years ...

In this interview, Melody Chang, RPh, BCOP, MBA, vice president of pharmacy operation at the American Oncology Network, discusses the network's pharmacy strategy and priorities. Melody Chang, RPh, ...